One

              Centrum f. int. Onko

 

                          Tüv 

 

          FOCUS 2018

                 DKG

 

                   CK CARE

 

                  GALEN.png

 

 
Two
Sie sind hier: Startseite Forschung Publikationen Publikationen 2012-2016

Publikationen 2012-2016

Ahmadzadehfar, H.; Wierzbicki, A.; Schmid-Wendtner, M.; Habibi, E.; Wenzel, J.; Muckle, M. et al. (2013): The probability of sentinel node positivity in patients with truncal melanoma with more than one drainage basin. In: Eur J Nucl Med Mol Imaging. 40 2, S379-S379.

Ahmadzadehfar, H.; Wierzbicki, A.; Schmid-Wendtner, M.; Wenzel, J.; Eichhorn, K.; Biersack, H. et al. (2013): Sensitivity and false negative rate of sentinel lymph node biopsy(SLNB) in malignant melanoma of different parts of the body. In: Eur J Nucl Med Mol Imaging. 40 2, S378-S379.

Al Ghazal, P.; Herberger, K.; Schaller, J.; Strölin, A.; Hoff, N. P.; Goerge, T. et al. (2013): Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany. A retrospective multicentric analysis in 259 patients. In: Orphanet J Rare Dis. 8, S. 136.

Allam, J.; Wustenberg, E.; Wolf, H.; Schnitker, J.; Bieber, T.; Novak, N. (2012): Vestibular administration of specific immunotherapy - a pilot study comparing sublingual and vestibular administration in patients with birch and tree allergy. In: Allergy. 67 96, S. 413.

Allam, J. P. (2013): … solves delicate Problems. Sperm Allergy. In: J Dtsch Dermatol Ges. 11 2, S. 61–62.

Allam, J. P. (2015): Klinefelter in dermatological Practice. How to recognize it and what to do? In: J Dtsch Dermatol Ges. 13 1, S. 58.

Allam, J. P.; Christ, L.; Novak, N. (2014): Predictive clinical parameters for adverse events in the course of sublingual immunotherapy. In: Allergy. 69 99, S. 414.

Allam, J. P.; Haidl, G. (2013): Sperm-Allergy. In: J Dtsch Dermatol Ges. 11 2, S. 12.

Allam, J. P.; Haidl, G.; Novak, N. (2015): [Semen allergy]. In: Hautarzt. 66 (12), S. 919–923.

Allam, J. P.; Novak, N. (2014): Immunological mechanisms of sublingual immunotherapy. In: Curr Opin Allergy Clin Immunol. 14 (6), S. 564–569.

Allam, J. P.; Richards, C.; Volk, J.; Wustenberg, E.; Serup-Hansen, N.; Andreasen, J. N. (2016): Allergy immunotherapy medication persistence and adherence with a SLIT-tablet and SCIT preparation in Germany. In: Allergy. 71 102, S. 250.

Allam, J. P.; Wuestenberg, E.; Wolf, H.; Klimek, L.; Decot, E.; Horn, A. et al. (2014): Immunologic response and safety in birch pollen sublingual versus oral vestibule immunotherapy. A pilot study. In: J Allergy Clin Immunol. 133 (6), 1757-9.e3.

Amsler, F.; Rabe, E.; Blättler, W. (2013): Leg symptoms of somatic, psychic, and unexplained origin in the population-based Bonn vein study. In: Eur J Vasc Endovasc Surg. 46 (2), S. 255–262.

Antignani, P. L.; Carpentier, P. H.; Cornu-Thenard, A.; Flour, M.; Partsch, H.; Rabe, E.; Uhl, J. F. (2012): UIP consensus on corona phlebectatica. In: Int Angiol. 31 (3), S. 217–218.

Ardern-Jones, M. R.; Bieber, T. (2014): Biomarkers in atopic dermatitis. It is time to stratify. In: Br J Dermatol. 171 (2), S. 207–208.

Baar, M.; Coquille, L.; Mayer, H.; Hölzel, M.; Rogava, M.; Tüting, T.; Bovier, A. (2016): A stochastic model for immunotherapy of cancer. In: Sci Rep. 6, S. 24169.

Bald, T.; Landsberg, J.; Jansen, P.; Gaffal, E.; Tuting, T. (2016): Chemical-induced neutrophilic inflammation promotes metastatic spread of melanoma. In: Exp Dermatol. 25 (3), E44-E44.

Bald, T.; Landsberg, J.; Jansen, P.; Gaffal, E.; Tüting, T. (2016): Phorbol ester-induced neutrophilic inflammatory responses selectively promote metastatic spread of melanoma in a TLR4-dependent manner. In: Oncoimmunology. 5 (2), e1078964.

Bald, T.; Landsberg, J.; Lopez-Ramos, D.; Renn, M.; Glodde, N.; Jansen, P. et al. (2014): Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation. In: Cancer Discov. 4 (6), S. 674–687.

Bald, T.; Landsberg, J.; Renn, M.; Mikus, S.; Limmer, A.; Quast, T. et al. (2012): Metastatic progression of melanoma is driven by Tlr4-dependent inflammatory responses in the tumor microenvironment. In: Exp Dermatol. 21 (3), e47-e47.

Bald, T.; Landsberg, J.; Renn, M.; Tueting, T. (2012): Metastatic progression of melanoma is driven by Tlr4-dependent inflammatory responses in the tumor microenvironment. In: J Invest Dermatol. 132 2, S126-S126.

Bald, T.; Landsberg, J.; Renn, M. R.; Tuting, T. (2013): Tlr4-dependent inflammation in the tumor microenvironment expands myeloid-derived suppressor cells that promote metastatic progression of melanoma in the Hgf-Cdk4 mouse model. In: Exp Dermatol. 22 (3), E39-E39.

Bald, T.; Quast, T.; Landsberg, J.; Rogava, M.; Glodde, N.; Lopez-Ramos, D. et al. (2014): Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. In: Nature. 507 (7490), S. 109–113.

Bald, T.; Rogava, M.; Landsberg, J.; Glodde, N.; Lopez-Ramos, D. A.; Gaffal, E.; Tueting, T. (2014): Ultraviolet radiation-induced neutrophilic inflammation promotes angiotropism and metastasis in melanoma. In: Exp Dermatol. 23 (3), E48-E48.

Banerjee, S.; Resch, Y.; Chen, K. W.; Swoboda, I.; Focke-Tejkl, M.; Blatt, K. et al. (2015): Der p 11 is a major allergen for house dust mite-allergic patients suffering from atopic dermatitis. In: J Invest Dermatol. 135 (1), S. 102–109.

Bangert, C.; Loesche, C.; Jones, J.; Weiss, D.; Bieber, T.; Stingl, G. (2016): Efficacy, safety and pharmacodynamics of a high-affinity anti-IgE antibody in patients with moderate to severe atopic dermatitis. A randomized, double-blind, placebo-controlled, proof-of-concept study. In: Exp Dermatol. 25 S4, S. 37.

Basmanav, B.; Oprisoreanu, A.; Fritz, G.; Wenzel, J.; Lestringant, G.; Thiele, H. et al. (2014): Mutations in POGLUT1 and POFUT1 cause Dowling-Degos disease and elucidate a gene-phenotype correlation. In: J Invest Dermatol. 134 2, S53-S53.

Basmanav, F. B.; Oprisoreanu, A. M.; Pasternack, S. M.; Thiele, H.; Fritz, G.; Wenzel, J. et al. (2014): Mutations in POGLUT1, encoding protein O-glucosyltransferase 1, cause autosomal-dominant Dowling-Degos disease. In: Am J Hum Genet. 94 (1), S. 135–143.

Battistella, M.; Bieber, T. (2014): The cutaneous bacteria. Our friends tomorrow? In: Ann Dermatol Venereol. 141, S. 30–31.

Battistella, M.; Bieber, T.; Bodemer, C. (2014): ATOPY, PEDIATRIC ALLERGOLOGY AND DERMATOLOGY The cutaneous microbiome. In: Ann Dermatol Venereol. 141 (2), S. 24–26.

Baurecht, H.; Hotze, M.; Brand, S.; Buning, C.; Cormican, P.; Corvin, A. et al. (2015): Genome-wide Comparative Analysis of Atopic Dermatitis and Psoriasis Gives Insight into Opposing Genetic Mechanisms (vol 96, pg 104, 2015). In: Am J Hum Genet. 97 (6), S. 933.

Baurecht, H.; Hotze, M.; Brand, S.; Büning, C.; Cormican, P.; Corvin, A. et al. (2015): Genome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms. In: Am J Hum Genet. 96 (1), S. 104–120.

Baurecht, H.; Schmitt, J.; Rodrguez, E.; Lieb, W.; Gieger, C.; Irvine, A. et al. (2016): Epidemiologic and genetic association between atopic dermatitis, rheumatoid arthritis, inflammatory bowel disease, and type-1 diabetes. In: Exp Dermatol. 25 (3), E16-E16.

Beck, L. A.; Thaçi, D.; Hamilton, J. D.; Graham, N. M.; Bieber, T.; Rocklin, R. et al. (2014): Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. In: N Engl J Med. 371 (2), S. 130–139.

Becker, K.; Meissner, V.; Farwick, W.; Bauer, R.; Gaiser, M. R. (2013): Lichen sclerosus and atopy in boys. Coincidence or correlation? In: Br J Dermatol. 168 (2), S. 362–366.

Benigni, J. P.; Bihari, I.; Rabe, E.; Uhl, J. F.; Partsch, H.; Cornu-Thenard, A. et al. (2013): Venous symptoms in C0 and C1 patients. UIP consensus document. In: Int Angiol. 32 (3), S. 261–265.

Bieber, T. (2012): Atopic dermatitis 2.0. From the clinical phenotype to the molecular taxonomy and stratified medicine. In: Allergy. 67 (12), S. 1475–1482.

Bieber, T. (2013): Atopic Dermatitis. Quo vadis? In: J Dtsch Dermatol Ges. 11 2, S. 55–56.

Bieber, T. (2013): Many ways lead to Rome. A glance at the multiple immunological pathways underlying atopic dermatitis. In: Allergy. 68 (8), S. 957–958.

Bieber, T. (2013): Treatment of atopic Dermatitis with a View to the Future. In: J Dtsch Dermatol Ges. 11 2, S. 69.

Bieber, T. (2014): Insights into immunoglobulin E-mediated late-phase reactions in dogs. In: Vet Dermatol. 25 (4), S. 305–306.

Bieber, T. (2014): Personalized medicine in allergy. Innovation or old hat? In: ALLERGOLOGIE. 37 (4), S. 133–134.

Bieber, T. (2016): Why we need a harmonized name for atopic dermatitis/atopic eczema/eczema! In: Allergy. 71 (10), S. 1379–1380.

Bieber, T.; Akdis, C.; Lauener, R.; Traidl-Hoffmann, C.; Schmid-Grendelmeier, P.; Schäppi, G. et al. (2016): Global Allergy Forum and 3rd Davos Declaration 2015. Atopic dermatitis/Eczema: challenges and opportunities toward precision medicine. In: Allergy. 71 (5), S. 588–592.

Bieber, T.; Broich, K. (2013): [Personalised medicine. Aims and challenges]. In: Bundesgesundheitsblatt Gesundheitsforschung, Gesundheitsschutz. 56 (11), S. 1468–1472.

Bieber, T.; Chosidow, O.; Bodsworth, N.; Tyring, S.; Hercogova, J.; Bloch, M. et al. (2014): Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP Trial). A double-blind, placebo-controlled, self-initiated trial. In: J Drugs Dermatol. 13 (7), S. 791–798.

Bieber, T.; Cork, M.; Reitamo, S. (2012): Atopic dermatitis. A candidate for disease-modifying strategy. In: Allergy. 67 (8), S. 969–975.

Bieber, T.; Kaiser, H. W. (2013): Professor Dr. med. Dr. h. c. mult. Hans Wilhelm Kreysel. In: J Dtsch Dermatol Ges. 11 (9), S. 893–894.

Bieber, T.; [Nachname nicht vorhanden] (2012): Role of Langerhans Cells and Inflammatory Dendritic Epidermal Cells In Atopic Dermatitis. In: Exp Dermatol. 21 (10), S. 807–808.

Bieber, T.; Straeter, B. (2015): Off-label prescriptions for atopic dermatitis in Europe. In: Allergy. 70 (1), S. 6–11.

Bieber, T.; Vieths, S.; Broich, K. (2016): New opportunities and challenges in the assessment of drugs for atopic diseases. In: Allergy. 71 (12), S. 1662–1665.

Bieber, ThomasRM; Thaci, Diamant; Graham, Neil; Pirozzi, Gianluca; Teper, Ariel; Ren, Haobo; Radin, Allen (2014): Dupilumab Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis. A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study. In: J Allergy Clin Immunol. 133 S (2), AB404-AB404.

Bilkei-Gorzo, A.; Drews, E.; Albayram, Ö.; Piyanova, A.; Gaffal, E.; Tueting, T. et al. (2012): Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1?/? mice. In: Neurobiol Aging. 33 (1), 200.e11-22.

Bisht, S.; Schlesinger, M.; Rupp, A.; Schubert, R.; Nolting, J.; Wenzel, J. et al. (2016): A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression. Towards future combination therapies. In: J Nanobiotechnology. 14 (1), S. 57.

Bousquet, J.; Farrell, J.; Crooks, G.; Hellings, P.; Bel, E. H.; Bewick, M. et al. (2016): Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3. Area 5). In: Clin Transl Allergy. 6, S. 29.

Bousquet, J.; Schunemann, H. J.; Fonseca, J.; Samolinski, B.; Bachert, C.; Canonica, G. W. et al. (2015): MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis). The new generation guideline implementation. In: Allergy. 70 (11), S. 1372–1392.

Bousquet, J.; Schünemann, H. J.; Samolinski, B.; Demoly, P.; Baena-Cagnani, C. E.; Bachert, C. et al. (2012): Allergic Rhinitis and its Impact on Asthma (ARIA). Achievements in 10 years and future needs. In: J Allergy Clin Immunol. 130 (5), S. 1049–1062.

Braegelmann, C.; Hölzel, M.; Ludbrook, V.; Dickson, M.; Turan, N.; Ferring-Schmitt, S. et al. (2016): Spleen tyrosine kinase (SYK) is a potential target for the treatment of cutaneous lupus erythematosus patients. In: Exp Dermatol. 25 (5), S. 375–379.

Braegelmann, J.; Braegelmann, C.; Wenzel, J. (2016): IL-36gamma/IL1-F9 immunohistology identifies psoriasis among erythroderma patients. In: Exp Dermatol. 25 (3), E14-E15.

Braegelmann, J.; D Erme, A. M.; Akmal, S.; Maier, J.; Braegelmann, C.; Wenzel, J. (2016): Interleukin-36? (IL-1F9) Identifies Psoriasis Among Patients With Erythroderma. In: Acta Derm Venereol. 96 (3), S. 386–387.

Bragelmann, C.; Holzel, M.; Ludbrook, V.; Dickson, M.; Turan, N.; Ferring-Schmitt, S. et al. (2016): Spleen tyrosine kinase (SYK) is a potential target for the treatment of cutaneous lupus erythematosus patients. In: J Dtsch Dermatol Ges. 14 2, S. 6.

Braun, A.; Bald, T.; Rogava, M.; Shridhar, N.; Tuting, T. (2016): Visualizing the dynamics of melanoma cell phenotypic plasticity in response to inflammatory and hypoxic environmental stimuli. In: Exp Dermatol. 25 (3), E42-E42.

Broich, K.; Bieber, T. (2013): [Personalised medicine]. In: Bundesgesundheitsblatt Gesundheitsforschung, Gesundheitsschutz. 56 (11), S. 1465–1467.

Brown, A.; Augustin, M.; Jünger, M.; Zutt, M.; Dissemond, J.; Rabe, E. et al. (2014): Randomized standard-of-care-controlled trial of a silica gel fibre matrix in the treatment of chronic venous leg ulcers. In: Eur J Dermatol. 24 (2), S. 210–216.

Bubnoff, D. von; Bieber, T. (2012): The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy. In: Allergy. 67 (6), S. 718–725.

Bubnoff, D. von; Sell, U.; Arriens, S.; Specht, S.; Hoerauf, A.; Bieber, T. (2012): Differential expression of toll-like receptor 2 on dendritic cells from asymptomatic and symptomatic atopic donors. In: Int Arch Allergy Immunol. 159 (1), S. 41–50.

Bubnoff, D. von; Zahn, S.; Wenzel, J.; Wilms, H.; Bieber, T.; Lüftl, M. (2012): Indoleamine 2,3-dioxygenase expression in early keratocyte neoplasia of the lower lip correlates to the degree of cell atypia. In: Pathol Int. 62 (2), S. 105–111.

Cabanillas, B.; Brendes, K.; Novak, N. (2016): Characerization of IgE-mediated reactivity against Herpes Simplex Virus 1 (HSV-1) in patients with atopic dermatitis complicated by eczema herpeticum. In: Allergy. 71 102, S. 68–69.

Cabanillas, B.; Crespo, J. F.; Maleki, S. J.; Rodriguez, J.; Novak, N. (2016): Pin p 1 is a major allergen in pine nut and the first food allergen described in the plant group of gymnosperms. In: Food Chem. 210, S. 70–77.

Cabanillas, B.; Cuadrado, C.; Rodriguez, J.; Hart, J.; Burbano, C.; Crespo, J. F.; Novak, N. (2015): Potential changes in the allergenicity of three forms of peanut after thermal processing. In: Food Chem. 183, S. 18–25.

Cabanillas, B.; Maleki, S. J.; Rodríguez, J.; Cheng, H.; Teuber, S. S.; Wallowitz, M. L. et al. (2014): Allergenic properties and differential response of walnut subjected to processing treatments. In: Food Chem. 157, S. 141–147.

Cabanillas, B.; Novak, N. (2015): Allergic Reactions to Pine Nut. A Review. In: J Investig Allergol Clin Immunol. 25 (5), S. 329–333.

Cabanillas, B.; Novak, N. (2016): Atopic dermatitis and filaggrin. In: Curr Opin Immunol. 42, S. 1–8.

Chen, S. J.; Allam, J. P.; Duan, Y. G.; Haidl, G. (2013): Influence of reactive oxygen species on human sperm functions and fertilizing capacity including therapeutical approaches. In: Arch Gynecol Obstet. 288 (1), S. 191–199.

Chen, S. J.; Duan, Y. G.; Haidl, G.; Allam, J. P. (2016): Predomination of IL-17-producing tryptase-positive/chymase-positive mast cells in azoospermic chronic testicular inflammation. In: Andrologia. 48 (6), S. 617–625.

Christ, L.; Wilhelm-Buchstab, T.; Landsberg, J. (2016): Autoimmune Hypophysitis after twice Anti-PD1-Antibody Administration and Long-term Release in a Female Patient with pulmonary metastatic Melanoma. In: J Dtsch Dermatol Ges. 14 4, S. 48.

Conrad, R.; Allam, J.; Geiser, F.; Haidl, G.; Karpawitz-Godt, A.; van der Ven, H. (2012): Expressive writing in male infertility - a randomized controlled study. In: J Psychosom Res. 72 (6), S. 475.

Cornelissen, C.; Marquardt, Y.; Czaja, K.; Amann, P.; Wenzel, J.; Frank, J. et al. (2012): IL-31 abrogates terminal cell differentiation and skin barrier function in human epidermal structures. In: Exp Dermatol. 21 (3), e3-e3.

Cornelissen, C.; Marquardt, Y.; Czaja, K.; Wenzel, J.; Frank, J.; Lüscher-Firzlaff, J. et al. (2012): IL-31 regulates differentiation and filaggrin expression in human organotypic skin models. In: J Allergy Clin Immunol. 129 (2), 426-33, 433.e1.

Cron, M.; Glodde, N.; Bald, T.; Jakobs, C.; Kuner, R.; Zimmer, A. et al. (2012): CB1 receptor deficiency in epidermal keratinocytes promotes contact allergic inflammation and delays epidermal barrier repair response. In: Exp Dermatol. 21 (3), e25-e25.

Cron, M.; Glodde, N.; Schroder, R.; Kostenis, E.; Tuting, T.; Gaffal, E. (2013): Beta arrestin-2 signalling attenuates contact allergic inflammation and modulates chemokine secretion of keratinocytes. In: Exp Dermatol. 22 (3), E3-E3.

Daeschlein, G.; Lutze, S.; Arnold, A.; Tueting, T.; Kiefer, T.; Emmert, S. et al. (2013): Cold Plasma as New Melanoma Treatment. Skin Melanoma Treatment in a Mouse Model. In: J Dtsch Dermatol Ges. 11 7, S. 53–54.

Daeschlein, G.; Scholz, S.; Lutze, S.; Arnold, A.; Podewils, S. von; Kiefer, T. et al. (2013): Comparison between cold plasma, electrochemotherapy and combined therapy in a melanoma mouse model. In: Exp Dermatol. 22 (9), S. 582–586.

Daßler-Plenker, J.; Reiners, K. S.; van den Boorn, J. G.; Hansen, H. P.; Putschli, B.; Barnert, S. et al. (2016): RIG-I activation induces the release of extracellular vesicles with antitumor activity. In: Oncoimmunology. 5 (10), e1219827.

Day, C. P.; Carter, J.; Weaver Ohler, Z.; Bonomi, C.; El Meskini, R.; Martin, P. et al. (2014): "Glowing head" mice. A genetic tool enabling reliable preclinical image-based evaluation of cancers in immunocompetent allografts. In: PLoS ONE. 9 (11), e109956.

DErme, A.; Bieber, T.; Wenzel, J. (2014): IL-36 gamma is a highly specific marker for psoriasis skin lesions. In: Exp Dermatol. 23 (3), E20-E20.

DErme, A. M.; Wilsmann-Theis, D.; Hoelzel, M.; Bieber, T.; Wenzel, J. (2014): IL-36 gamma (IL-1F9) is a specific Marker of Psoriasis. In: J Dtsch Dermatol Ges. 12 (12), E13-E13.

D'Erme, A. M.; Wilsmann-Theis, D.; Wagenpfeil, J.; Hölzel, M.; Ferring-Schmitt, S.; Sternberg, S. et al. (2015): IL-36? (IL-1F9) Is a Biomarker for Psoriasis Skin Lesions. In: J Invest Dermatol. 135 (4), S. 1025–1032.

Dharmarajah, B.; Lane, T. R.A.; Moore, H. M.; Neumann, H. A.M.; Rabe, E.; Wittens, C. H.A.; Davies, A. H. (2014): The Future of Phlebology in Europe. In: Phlebology. 29 1, S. 181–185.

Dreno, B.; Araviiskaia, E.; Berardesca, E.; Bieber, T.; Hawk, J.; Sanchez-Viera, M.; Wolkenstein, P. (2014): The science of dermocosmetics and its role in dermatology. In: J Eur Acad Dermatol Venereol. 28 (11), S. 1409–1417.

Dréno, B.; Araviiskaia, E.; Berardesca, E.; Gontijo, G.; Sanchez Viera, M.; Xiang, L. F. et al. (2016): Microbiome in healthy skin, update for dermatologists. In: J Eur Acad Dermatol Venereol. 30 (12), S. 2038–2047.

Ellinghaus, D.; Baurecht, H.; Esparza-Gordillo, J.; Rodríguez, E.; Matanovic, A.; Marenholz, I. et al. (2013): High-density genotyping study identifies four new susceptibility loci for atopic dermatitis. In: Nat Genet. 45 (7), S. 808–812.

Eyerich, K.; Novak, N. (2013): Immunology of atopic eczema. Overcoming the Th1/Th2 paradigm. In: Allergy. 68 (8), S. 974–982.

Ezziddin, S.; Khalaf, F.; Seidel, M.; Al Zreiqat, A.; Wilsmann-Theis, D.; Simon, B. et al. (2015): Introduction of a metabolic joint asymmetry score derived from conventional bone scintigraphy. A new tool to differentiate psoriatic from rheumatoid arthritis. In: Nuklearmedizin. 54 (4), S. 183–189.

Fathy, A.; Chen, S. J.; Novak, N.; Schuppe, H. C.; Haidl, G.; Allam, J. P. (2014): Differential leucocyte detection by flow cytometry improves the diagnosis of genital tract inflammation and identifies macrophages as proinflammatory cytokine-producing cells in human semen. In: Andrologia. 46 (9), S. 1004–1012.

Fijak, M.; Zeller, T.; Huys, T.; Klug, J.; Wahle, E.; Linder, M. et al. (2014): Autoantibodies against protein disulfide isomerase ER-60 are a diagnostic marker for low-grade testicular inflammation. In: Hum Reprod. 29 (11), S. 2382–2392.

Fons, M. A.F.; Maintz, L.; Konig, D. P. (2014): Quality of Post-Operative Pain Therapy after Subacromial Decompression of the Shoulder with Resection of the Lateral Clavicula by Arthroscopy. In: Z Orthop Unfall. 152 (4), S. 369–374.

Forat, S.; Huettel, B.; Reinhardt, R.; Fimmers, R.; Haidl, G.; Denschlag, D.; Olek, K. (2016): Methylation Markers for the Identification of Body Fluids and Tissues from Forensic Trace Evidence. In: PLoS ONE. 11 (2), e0147973.

Frohlich, A.; Landsberg, J. (2016): Abscopal Effect in a metastatic Melanoma Patient after Progress under Anti-PD1-Therapy. In: J Dtsch Dermatol Ges. 14 4, S. 38–39.

Fronhoffs, K.; Rehkamper-Schafer, C.; Altengarten, J.; Bieber, T. (2014): Skin Picking-Syndrom. In: J Dtsch Dermatol Ges. 12 (12), E12-E12.

Gaffal, E.; Cron, M.; Glodde, N.; Bald, T.; Kuner, R.; Zimmer, A. et al. (2012): CB1 receptor deletion specifically on keratinocytes leads to enhanced IFN gamma-dependent secretion of proinflammatory chemokines and increased allergic contact hypersensitivity. In: J Invest Dermatol. 132 2, S2-S2.

Gaffal, E.; Cron, M.; Glodde, N.; Bald, T.; Kuner, R.; Zimmer, A. et al. (2013): Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation. In: J Immunol. 190 (10), S. 4929–4936.

Gaffal, E.; Cron, M.; Glodde, N.; Schroeder, R.; Kostenis, E.; Tueting, T. (2013): Beta arrestin-2 signalling attenuates contact allergic inflammation and inhibits proinflammatory chemokine production by keratinocytes. In: J Invest Dermatol. 133 1, S9-S9.

Gaffal, E.; Cron, M.; Glodde, N.; Tüting, T. (2013): Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors. In: Allergy. 68 (8), S. 994–1000.

Gaffal, E.; Glodde, N.; Jakobs, M.; Bald, T.; Tüting, T. (2014): Cannabinoid 1 receptors in keratinocytes attenuate fluorescein isothiocyanate-induced mouse atopic-like dermatitis. In: Exp Dermatol. 23 (6), S. 401–406.

Gaffal, E.; Jakobs, M.; Glodde, N.; Schröder, R.; Kostenis, E.; Tüting, T. (2014): ?-arrestin 2 inhibits proinflammatory chemokine production and attenuates contact allergic inflammation in the skin. In: J Invest Dermatol. 134 (8), S. 2131–2137.

Garmhausen, D.; Hagemann, T.; Bieber, T.; Dimitriou, I.; Fimmers, R.; Diepgen, T.; Novak, N. (2013): Characterization of different courses of atopic dermatitis in adolescent and adult patients. In: Allergy. 68 (4), S. 498–506.

Giebeler, N.; Schonefu, A.; Landsberg, J.; Tuting, T.; Mauch, C.; Zigrino, P. (2016): ADAM-9 modulates melanoma development and metastasis in vivo. In: Exp Dermatol. 25 (3), E38-E38.

Glodde, N.; Bald, T.; van den Boorn-Konijnenberg, D.; Schmid-Burgk, J.; Hornung, V.; Tuting, T.; Holzel, M. (2016): Modelling genetic heterogeneity as a resistance mechanism to cancer immunotherapy using CRISPR-Cas9. In: Exp Dermatol. 25 (3), E42-E42.

Glodde, N.; Cron, M.; Steuder, R.; Zimmer, A.; Tuting, T.; Gaffal, E. (2013): Topical application of Delta 9-tetrahydrocannabinol attenuates contact allergic inflammation through cannabinoid receptor 1/2-independent effects on keratinocytes. In: Exp Dermatol. 22 (3), E2-E2.

Glodde, N.; Jakobs, M.; Bald, T.; Tüting, T.; Gaffal, E. (2015): Differential role of cannabinoids in the pathogenesis of skin cancer. In: Life Sci. 138, S. 35–40.

Glowka, T.; Landsberg, J.; Keyver-Paik, M.; Thiesler, T.; Kalff, J.; Pantelis, D. (2016): Surgical Procedure in anorectal Melanoma - a unicentric retrospective Case Series. In: J Dtsch Dermatol Ges. 14 4, S. 1.

Glowka, T. R.; Keyver-Paik, M. D.; Thiesler, T.; Landsberg, J.; Kalff, J. C.; Pantelis, D. (2016): [Anorectal malignant melanoma. Treatment recommendations]. In: Chirurg. 87 (9), S. 768–774.

Goltz, D.; Gevensleben, H.; Dietrich, J.; Ellinger, J.; Landsberg, J.; Kristiansen, G.; Dietrich, D. (2016): Promoter methylation of the immune checkpoint receptor PD-1 (PDCD1) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy. In: Oncoimmunology. 5 (10), e1221555.

Gölz, L.; Simonis, R. A.; Reichelt, J.; Stark, H.; Frentzen, M.; Allam, J. P. et al. (2016): In vitro biocompatibility of ICON(®) and TEGDMA on human dental pulp stem cells. In: Dent Mater. 32 (8), S. 1052–1064.

Gros, E.; Novak, N. (2012): Cutaneous dendritic cells in allergic inflammation. In: Clin Exp Allergy. 42 (8), S. 1161–1175.

Guex, J. J.; Rabe, E. (2013): International Union of Phlebology (IUP). History, role and future. Its development between the 2009 Monaco Congress and the 2013 Boston Congress. In: Phlebol -Ann Vasc. 66 (3), S. 7–8.

Habenicht, M.; Rabe, E.; Amsler, F.; Mendoza, E. (2016): Toe elevation manoeuvre to assess venous reflux in comparison to manual calf compression and release. In: Vasa. 45 (4), S. 299–304.

Hadizadeh, D. R.; Kukuk, G. M.; Fahlenkamp, U. L.; Pressacco, J.; Schäfer, C.; Rabe, E. et al. (2012): Simultaneous MR arteriography and venography with blood pool contrast agent detects deep venous thrombosis in suspected arterial disease. In: AJR Am J Roentgenol. 198 (5), S. 1188–1195.

Hahn, S. A.; Neuhoff, A.; Landsberg, J.; Schupp, J.; Eberts, D.; Leukel, P. et al. (2016): A key role of GARP in the immune suppressive tumor microenvironment. In: Oncotarget. 7 (28), S. 42996–43009.

Haidl, F.; Haidl, G.; Oltermann, I.; Allam, J. P. (2015): Seminal parameters of chronic male genital inflammation are associated with disturbed sperm DNA integrity. In: Andrologia. 47 (4), S. 464–469.

Haidl, G. (2013): Penile Dermatoses of the aging Male. In: J Dtsch Dermatol Ges. 11 2, S. 61.

Haidl, G. (2014): Commentary on "Decline of semen quality during IVF is not associated with subjective male stress'. In: Asian J Androl. 16 (4), 640; discussion 640.

Haidl, G. (2015): Commentary on "Awareness of and attitudes toward infertility and its treatment. A cross-sectional survey of men in a United States primary care population". In: Asian J Androl. 17 (1), S. 162.

Herrmann, N.; Koch, S.; Leib, N.; Bedorf, J.; Wilms, H.; Schnautz, S. et al. (2013): TLR2 down-regulates Fc?RI and its transcription factor PU.1 in human Langerhans cells. In: Allergy. 68 (5), S. 621–628.

Hinz, T.; Ahmadzadehfar, H.; Wierzbicki, A.; Hoeller, T.; Wenzel, J.; Biersack, H. J. et al. (2012): Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm). Outcome analysis from a single institution. In: Eur J Nucl Med Mol Imaging. 39 (8), S. 1316–1325.

Hinz, T.; Ahmadzadehfar, H.; Wierzbicki, A.; Höller, T.; Wenzel, J.; Biersack, H. J. et al. (2012): Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness <1.00 mm) on the basis of a long-term follow-up. In: Eur J Nucl Med Mol Imaging. 39 (4), S. 581–588.

Hinz, T.; Ehler, L. K.; Bieber, T.; Schmid-Wendtner, M. H. (2013): Complete remission of extensive cutaneous metastatic melanoma on the scalp under topical mono-immunotherapy with diphenylcyclopropenone. In: Eur J Dermatol. 23 (4), S. 532–533.

Hinz, T.; Ehler, L. K.; Hornung, T.; Voth, H.; Fortmeier, I.; Maier, T. et al. (2012): Preoperative characterization of basal cell carcinoma comparing tumour thickness measurement by optical coherence tomography, 20-MHz ultrasound and histopathology. In: Acta Derm Venereol. 92 (2), S. 132–137.

Hinz, T.; Hoeller, T.; Bieber, T.; Blum, A.; Schmid-Wendtner, M. H. (2012): Influence of sporting activity and smoking on peripheral lymph nodes in patients with melanoma analyzed by high-resolution ultrasound. In: J Am Acad Dermatol. 67 (5), S. 853–860.

Hinz, T.; Hoeller, T.; Wenzel, J.; Bieber, T.; Schmid-Wendtner, M. H. (2013): Real-time tissue elastography as promising diagnostic tool for diagnosis of lymph node metastases in patients with malignant melanoma. A prospective single-center experience. In: Dermatology. 226 (1), S. 81–90.

Hinz, T.; Hornung, T.; Wenzel, J.; Bieber, T. (2013): Lupus tumidus following the lines of Blaschko. In: Int J Dermatol. 52 (12), S. 1615–1617.

Hinz, T.; Voth, H.; Ahmadzadehfar, H.; Hoeller, T.; Wenzel, J.; Bieber, T.; Schmid-Wendtner, M. H. (2013): Role of high-resolution ultrasound and PET/CT imaging for preoperative characterization of sentinel lymph nodes in cutaneous melanoma. In: Ultrasound Med Biol. 39 (1), S. 30–36.

Hölzel, M.; Bovier, A.; Tüting, T. (2013): Plasticity of tumour and immune cells. A source of heterogeneity and a cause for therapy resistance? In: Nat Rev Cancer. 13 (5), S. 365–376.

Hölzel, M.; Landsberg, J.; Glodde, N.; Bald, T.; Rogava, M.; Riesenberg, S. et al. (2016): A Preclinical Model of Malignant Peripheral Nerve Sheath Tumor-like Melanoma Is Characterized by Infiltrating Mast Cells. In: Cancer Res. 76 (2), S. 251–263.

Hölzel, M.; Tüting, T. (2016): Inflammation-Induced Plasticity in Melanoma Therapy and Metastasis. In: Trends Immunol. 37 (6), S. 364–374.

Hoppe, T.; Kraus, D.; Novak, N.; Probstmeier, R.; Frentzen, M.; Wenghoefer, M. et al. (2016): Oral pathogens change proliferation properties of oral tumor cells by affecting gene expression of human defensins. In: Tumour Biol. 37 (10), S. 13789–13798.

Hornung, T.; Hufnagel, J.; Bieber, T.; Wenzel, J. (2013): Successful treatment of Pyoderma gangrenosum with Mycofenolat mofetil in a Patient with SLE. In: J Dtsch Dermatol Ges. 11 (11), S. 1118.

Hornung, T.; Janzen, V.; Wenzel, J. (2014): Remission of Recalcitrant Dermatomyositis Treated with Ruxolitinib. In: N Engl J Med. 371 (26), S. 2537–2538.

Hornung, T.; Ko, A.; Tüting, T.; Bieber, T.; Wenzel, J. (2012): Efficacy of low-dose methotrexate in the treatment of dermatomyositis skin lesions. In: Clin Exp Dermatol. 37 (2), S. 139–142.

Hornung, T.; Wenzel, J. (2014): Innate immune-response mechanisms in dermatomyositis. An update on pathogenesis, diagnosis and treatment. In: Drugs. 74 (9), S. 981–998.

Hornung, T.; Wolf, D.; Wenzel, J. (2015): More on remission of recalcitrant dermatomyositis treated with ruxolitinib. In: N Engl J Med. 372 (13), S. 1274.

Hotze, M.; Baurecht, H.; Rodriguez, E.; Elder, J. T.; Franke, A.; Novak, N. et al. (2014): Genome-wide comparative analysis of atopic eczema and psoriasis gives insight into disease mechanisms. In: Exp Dermatol. 23 (3), E21-E21.

Hufnagel, J.; Berboth, G.; Altengarten, J.; Wenzel, J. (2014): Urbach-Wiethe-Disease (Hyalinosis cutis et mucosae). In: J Dtsch Dermatol Ges. 12 (12), E2-E2.

Jakobs, C.; Tueting, T.; Hornung, V. (2012): Impact of AIM2-Inflammasome activation on adaptive immune responses after cutaneous DNA-Vaccination. In: Immunology. 137 1, S. 5.

Kaemper, Nadine; Franken, Sebastian; Temme, Sebastian; Koch, Susanne; Bieber, Thomas; Koch, Norbert (2012): gamma-Interferon-regulated chaperone governs human lymphocyte antigen class II expression. In: FASEB J. 26 (1), S. 104–116.

Kebir, S.; Kimmich, O.; Niehusmann, P.; Gaertner, F. C.; Essler, M.; Landsberg, J. et al. (2016): (18)F-fluoroethyl-L-tyrosine positron emission tomography-guided diagnosis of a malignant intramedullary spinal cord tumor. In: Oncol Lett. 12 (6), S. 4705–4707.

Kebir, S.; Rauschenbach, L.; Galldiks, N.; Schlaak, M.; Hattingen, E.; Landsberg, J. et al. (2016): Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastases. In: Neuro-oncol. 18 (10), S. 1462–1464.

Kezic, S.; Novak, N.; Jakasa, I.; Jungersted, J. M.; Simon, M.; Brandner, J. M. et al. (2014): Skin barrier in atopic dermatitis. In: Front Biosci (Landmark Ed). 19, S. 542–556.

Kilian, M. M.; Herwig, M. C.; Holz, F. G.; Tüting, T.; Loeffler, K. U. (2016): Overexpression of hepatocyte growth factor and an oncogenic CDK4 variant in mice alters corneal stroma morphology but does not lead to spontaneous ocular melanoma. In: Melanoma Res. 26 (1), S. 89–91.

Klaeschen, A. S.; Wenzel, J. (2016): Upcoming therapeutic targets in cutaneous lupus erythematous. In: Expert Rev Clin Pharmacol. 9 (4), S. 567–578.

Kohlmeyer, J.; Jonen, E.; Landsberg, J.; Rogava, M.; Bald, T.; Aymans, P. et al. (2014): Functional role of Ngfr signaling in human melanoma cell lines. In: Exp Dermatol. 23 (3), E48-E48.

Kohlmeyer, J.; Landsberg, J.; Ratering, E.; Tueting, T. (2016): Progression of melanoma is associated with an increased expression of Ngfr - a histopathological correlation in human primary melanomas and skin metastases. In: J Invest Dermatol. 136 2 (9), S242-S242.

Kohlmeyer, J.; Landsberg, J.; Ratering, E.; Tuting, T. (2016): The role of Ngfr expression in the progression of malignant melanoma - a histopathological correlation in human primary melanomas and skin metastases. In: Exp Dermatol. 25 (3), E15-E15.

Kohlmeyer, J.; Landsberg, J.; Renn, M.; Bald, T.; Gaffal, E.; Mikus, S. et al. (2012): An inflammatory microenvironment promotes dedifferentiation of Hgf-Cdk4R24C melanoma cells leading to impaired recognition by gp100-specific CD8+T-cells. In: Exp Dermatol. 21 (3), e44-e44.

Kohlmeyer, J.; Landsberg, J.; Renn, M.; Bald, T.; Rogava, M.; Cron, M. et al. (2013): Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. In: J Invest Dermatol. 133 1, S230-S230.

Kohlmeyer, J.; Rogava, M.; Landsberg, J.; Renn, M. R.; Bald, T.; Fatho, M. et al. (2013): TNF-alpha reversibly shifts melanoma cells towards a dedifferentiated state leading to selectively impaired recognition by CD8+T-cells specific for pigmentation antigens. In: Exp Dermatol. 22 (3), E41-E41.

Konermann, A.; Beyer, M.; Deschner, J.; Allam, J. P.; Novak, N.; Winter, J. et al. (2012): Human periodontal ligament cells facilitate leukocyte recruitment and are influenced in their immunomodulatory function by Th17 cytokine release. In: Cell Immunol. 272 (2), S. 137–143.

Konermann, A.; Deschner, J.; Allam, J. P.; Novak, N.; Winter, J.; Baader, S. L. et al. (2012): Antigen-presenting cell marker expression and phagocytotic activity in periodontal ligament cells. In: J Oral Pathol Med. 41 (4), S. 340–347.

Konermann, A.; Winter, J.; Novak, N.; Allam, J. P.; Jäger, A. (2013): Verification of IL-17A and IL-17F in oral tissues and modulation of their expression pattern by steroid hormones. In: Cell Immunol. 285 (1-2), S. 133–140.

Korber, A.; Mossner, R.; Renner, R.; Sticht, H.; Traupe, H.; Wilsmann-Theis, D. et al. (2013): Mutations of IL36RN in four patients with generalized pustular psoriasis of German, Turkish and Iraquian origin. In: Exp Dermatol. 22 (3), E22-E22.

Körber, A.; Mössner, R.; Renner, R.; Sticht, H.; Wilsmann-Theis, D.; Schulz, P. et al. (2013): Mutations in IL36RN in patients with generalized pustular psoriasis. In: J Invest Dermatol. 133 (11), S. 2634–2637.

Kotarba, A.; Gevensleben, H.; Goltz, D.; Dietrich, D.; Landsberg, J. (2016): Case Presentation. One Patient - three metastatic Malignomas. In: J Dtsch Dermatol Ges. 14 4, S. 46.

Kraus, D.; Deschner, J.; Jäger, A.; Wenghoefer, M.; Bayer, S.; Jepsen, S. et al. (2012): Human ?-defensins differently affect proliferation, differentiation, and mineralization of osteoblast-like MG63 cells. In: J Cell Physiol. 227 (3), S. 994–1003.

Kraus, D.; Reckenbeil, J.; Wenghoefer, M.; Stark, H.; Frentzen, M.; Allam, J. P. et al. (2016): Ghrelin promotes oral tumor cell proliferation by modifying GLUT1 expression. In: Cell Mol Life Sci. 73 (6), S. 1287–1299.

Kreuter, A.; Krieg, T.; Worm, M.; Wenzel, J.; Moinzadeh, P.; Kuhn, A. et al. (2016): German guidelines for the diagnosis and therapy of localized scleroderma. In: J Dtsch Dermatol Ges. 14 (2), S. 199–216.

Kreuter, A.; Krieg, T.; Worm, M.; Wenzel, J.; Moinzadeh, P.; Kuhn, A. et al. (2016): German guidelines for the diagnosis and therapy of localized scleroderma. In: J Dtsch Dermatol Ges. 14 (2), E1-E19.

Krohne, T. U.; Allam, J. P.; Novak, N.; Holz, F. G. (2016): ["Iodine allergy". A medical myth with risks for the ophthalmological patient]. In: Ophthalmologe. 113 (12), S. 1023–1028.

Kühborth, K.; Haidl, G.; Allam, J. P. (2015): [Penile dermatoses]. In: Urologe A. 54 (5), S. 684–689.

Kuhn, A.; Landmann, A.; Wenzel, J. (2016): Advances in the treatment of cutaneous lupus erythematosus. In: Lupus. 25 (8), S. 830–837.

Kuhn, A.; Wenzel, J.; Bijl, M. (2016): Lupus erythematosus revisited. In: Semin Immunopathol. 38 (1), S. 97–112.

Kuhn, A.; Wenzel, J.; Weyd, H. (2014): Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus. A critical review. In: Clin Rev Allergy Immunol. 47 (2), S. 148–162.

Kunsleben, N.; Rüdrich, U.; Gehring, M.; Novak, N.; Kapp, A.; Raap, U. (2015): IL-31 Induces Chemotaxis, Calcium Mobilization, Release of Reactive Oxygen Species, and CCL26 in Eosinophils, Which Are Capable to Release IL-31. In: J Invest Dermatol. 135 (7), S. 1908–1911.

Kunz, M.; Konig, I. R.; Ziegler, A.; Ranki, A.; Koskenmies, S.; Ronn, A. et al. (2016): Genome-wide association study identifies new susceptibility loci for cutaneous lupus erythematosus. In: Exp Dermatol. 25 (3), E18-E18.

Kunz, M.; König, I. R.; Schillert, A.; Kruppa, J.; Ziegler, A.; Grallert, H. et al. (2015): Genome-wide association study identifies new susceptibility loci for cutaneous lupus erythematosus. In: Exp Dermatol. 24 (7), S. 510–515.

Landsberg, J.; Holzel, M.; Glodde, N.; Bald, T.; Rogava, M.; Becker, A. et al. (2016): A malignant peripheral nerve sheath tumor-like melanoma phenotype orchestrates mast cell recruitment. In: Exp Dermatol. 25 (3), E44-E44.

Landsberg, J.; Kohlmeyer, J.; Renn, M.; Bald, T.; Holzel, M.; Tuting, T. (2013): Hgf-Cdk4 Mouse Melanomas Resist T-cell Therapy Through Inflammation-Induced Reversible Dedifferentiation. In: J Dtsch Dermatol Ges. 11 7, S. 10.

Landsberg, J.; Kohlmeyer, J.; Renn, M.; Bald, T.; Rogava, M.; Cron, M. et al. (2012): Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. In: Nature. 490 (7420), S. 412–416.

Landsberg, J.; Kohlmeyer, J.; Renn, M.; Bald, T.; Tueting, T. (2012): Hgf-Cdk4(R24C) mouse melanomas resist T-cell therapy targeting a melanocytic antigen through inflammation-induced reversible dedifferentiation. In: J Invest Dermatol. 132 2, S124-S124.

Landsberg, J.; Kohlmeyer, J.; Renn, M. R.; Bald, T.; Sporleder, A.; Lemke, C. et al. (2013): Melanoms resist adoptive T-cell therapy through inflammation-induced reversible dedifferentiation. In: Exp Dermatol. 22 (3), E40-E40.

Landsberg, J.; Renn, M.; Bald, T.; Kohlmeyer, J.; Cron, M.; Mikus, S. et al. (2012): Long-term immune surveillance by gp100-specific pmel1 T-cells induces an inflammatory tumor microenvironment in primary cutaneous Hgf-Cdk4R24C mouse melanomas. In: Exp Dermatol. 21 (3), e44-e44.

Landsberg, J.; Rogava, M.; Bald, T.; Kohlmeyer, J.; Sporleder, A.; Renn, M. et al. (2014): Increased angiotropism in the inflammatory microenvironment of melanomas acquired resistance to adoptive T cell therapy compared to untreated controls. In: Exp Dermatol. 23 (3), E50-E50.

Landsberg, J.; Tüting, T.; Barnhill, R. L.; Lugassy, C. (2016): The Role of Neutrophilic Inflammation, Angiotropism, and Pericytic Mimicry in Melanoma Progression and Metastasis. In: J Invest Dermatol. 136 (2), S. 372–377.

Langley, R. G.; Elewski, B. E.; Lebwohl, M.; Reich, K.; Griffiths, C. E.; Papp, K. et al. (2014): Secukinumab in plaque psoriasis--results of two phase 3 trials. In: N Engl J Med. 371 (4), S. 326–338.

Lee, B. B.; Antignani, P. L.; Baraldini, V.; Baumgartner, I.; Berlien, P.; Blei, F. et al. (2015): ISVI-IUA consensus document diagnostic guidelines of vascular anomalies. Vascular malformations and hemangiomas. In: Int Angiol. 34 (4), S. 333–374.

Lee, B. B.; Baumgartner, I.; Berlien, P.; Bianchini, G.; Burrows, P.; Gloviczki, P. et al. (2015): Diagnosis and Treatment of Venous Malformations. Consensus Document of the International Union of Phlebology (IUP). Updated 2013. In: Int Angiol. 34 (2), S. 97–149.

Lenormand, C.; Bausinger, H.; Gross, F.; Signorino-Gelo, F.; Koch, S.; Peressin, M. et al. (2012): HLA-DQA2 and HLA-DQB2 genes are specifically expressed in human Langerhans cells and encode a new HLA class II molecule. In: J Immunol. 188 (8), S. 3903–3911.

Lewalter, T.; Weiss, C.; Mewis, C.; Spencker, S.; Lickfett, L.; Jung, W. et al. (2012): Operator chosen procedural variables determine the effectiveness of cavotricuspid isthmus ablation. A post-hoc analysis of the aurum 8 study. In: Eur Heart J. 33 1, S. 985.

Lisson, M.; Novak, N.; Erhardt, G. (2014): Immunoglobulin E epitope mapping by microarray immunoassay reveals differences in immune response to genetic variants of caseins from different ruminant species. In: J Dairy Sci. 97 (4), S. 1939–1954.

Lopez-Ramos, D. A.; Bald, T.; Tuting, T. (2014): Efficient adoptive T cell therapy against melanoma in the absence of type I interferon system. In: Exp Dermatol. 23 (3), E32-E32.

Lu, K. H.; Tounsi, A.; Shridhar, N.; Küblbeck, G.; Klevenz, A.; Prokosch, S. et al. (2015): Dickkopf-3 Contributes to the Regulation of Anti-Tumor Immune Responses by Mesenchymal Stem Cells. In: Front Immunol. 6, S. 645.

Magerl, M.; Rother, M.; Bieber, T.; Biedermann, T.; Brasch, J.; Dominicus, R. et al. (2013): Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticaria. In: J Eur Acad Dermatol Venereol. 27 (3), e363-9.

Maier, T.; Braun-Falco, M.; Hinz, T.; Schmid-Wendtner, M. H.; Ruzicka, T.; Berking, C. (2013): Morphology of basal cell carcinoma in high definition optical coherence tomography. En-face and slice imaging mode, and comparison with histology. In: J Eur Acad Dermatol Venereol. 27 (1), e97-104.

Maintz, L.; Wenzel, J.; Reinhard, H.; Bieber, T. (2014): Successful treatment of systemic juvenile xanthogranulomatosis with cytarabine and 2-chlorodeoxydenosine. In: J Dtsch Dermatol Ges. 12 (12), E12-E12.

Manz, J.; Rodríguez, E.; ElSharawy, A.; Oesau, E. M.; Petersen, B. S.; Baurecht, H. et al. (2016): Targeted Resequencing and Functional Testing Identifies Low-Frequency Missense Variants in the Gene Encoding GARP as Significant Contributors to Atopic Dermatitis Risk. In: J Invest Dermatol. 136 (12), S. 2380–2386.

Meister, M.; Tounsi, A.; Bald, T.; Papatriantafyllou, M.; Gaffal, E.; Moldenhauer, G. et al. (2013): Neo-self antigen presentation by keratinocytes under inflammatory conditions can modulate systemic CD4 T cell responses. In: Immunology. 140 1, S. 44.

Meister, M.; Tounsi, A.; Gaffal, E.; Bald, T.; Papatriantafyllou, M.; Ludwig, J. et al. (2015): Self-Antigen Presentation by Keratinocytes in the Inflamed Adult Skin Modulates T-Cell Auto-Reactivity. In: J Invest Dermatol. 135 (8), S. 1996–2004.

Mengoni, M.; Shridhar, N.; Braun, A.; Bald, T.; Gaffal, E.; Tuting, T. (2016): Role of the aryl hydrocarbon receptor pathway in melanoma pathogenesis. In: Exp Dermatol. 25 (3), E44-E44.

Merlino, G.; Herlyn, M.; Fisher, D. E.; Bastian, B. C.; Flaherty, K. T.; Davies, M. A. et al. (2016): The state of melanoma. Challenges and opportunities. In: Pigment Cell Melanoma Res. 29 (4), S. 404–416.

Mescher, M.; Jeong, P.; Rubsam, M.; Kranen, M.; Landsberg, J.; Schlaak, M. et al. (2016): Non-cell autonomous suppression of melanoma by the epidermal polarity protein Par3 through control of direct keratinocyte-melanocyte interactions. In: J Invest Dermatol. 136 2 (9), S244-S244.

Micali, G.; Wilsmann-Theis, D.; Mallbris, L.; Gallo, G.; Marino, V.; Brault, Y.; Germain, J. M. (2015): Etanercept reduces symptoms and severity of psoriasis after cessation of cyclosporine therapy. Results of the SCORE study. In: Acta Derm Venereol. 95 (1), S. 57–61.

Mihic-Probst, D.; Shea, C.; Duncan, L.; La Fouchardiere, A. de; Landman, G.; Landsberg, J. et al. (2016): Update on Thin Melanoma. Outcome of an International Workshop. In: Adv Anat Pathol. 23 (1), S. 24–29.

Moro, N.; Schoenefuss, A.; Landsberg, J.; Tueting, T.; Mauch, C.; Zigrino, P. (2014): Dual role for ADAM-9 in melanoma development and metastasis in vivo. In: J Invest Dermatol. 134 2, S90-S90.

Moro, N.; Schonefuss, A.; Landsberg, J.; Tuting, T.; Mauch, C.; Zigrino, P. (2014): ADAM-9 deletion in an animal model with spontaneous melanoma development reduces lung metastases formation. In: Exp Dermatol. 23 (3), E43-E44.

Moro, N.; Schonefuss, A.; Landsberg, J.; Tuting, T.; Mauch, C.; Zigrino, P. (2014): DELETION OF ADAM-9 IN AN ANIMAL MODEL WITH SPONTANEOUS MELANOMA DEVELOPMENT REDUCES LUNG METASTASIS FORMATION. In: Wound Repair Regen. 22 (5), A92-A92.

Mossner, R.; Frambach, Y.; Jacobi, A.; Muller, M.; Oji, V.; Philipp, S. et al. (2014): Palmoplantar pustular psoriasis and its genetic background. In: Exp Dermatol. 23 (3), E23-E23.

Mossner, R.; Frambach, Y.; Wilsmann-Theis, D.; Lohr, S.; Jacobi, A.; Weyergraf, A. et al. (2014): Palmoplantar pustular psoriasis is associated with a missense variant in CARD14 in European patients. In: Br J Dermatol. 171 (6), E113-E113.

Mössner, R.; Frambach, Y.; Wilsmann-Theis, D.; Löhr, S.; Jacobi, A.; Weyergraf, A. et al. (2015): Palmoplantar Pustular Psoriasis Is Associated with Missense Variants in CARD14, but Not with Loss-of-Function Mutations in IL36RN in European Patients. In: J Invest Dermatol. 135 (10), S. 2538–2541.

Mosti, G.; Maeseneer, M. de; Cavezzi, A.; Parsi, K.; Morrison, N.; Nelzen, O. et al. (2015): Society for Vascular Surgery and American Venous Forum Guidelines on the management of venous leg ulcers. The point of view of the International Union of Phlebology. In: Int Angiol. 34 (3), S. 202–218.

Mrowietz, U.; Altmeyer, P.; Augustin, M.; Boehncke, W. H.; Bonnekoh, B.; Frambach, Y. et al. (2012): New Insights into Tumaric Acid Esters (Fumaderm (R)). Results of the second Expert Workshops. In: J Dtsch Dermatol Ges. 10 8, S. 1–15.

Muraro, A.; Lemanske, R. F.; Hellings, P. W.; Akdis, C. A.; Bieber, T.; Casale, T. B. et al. (2016): Precision medicine in patients with allergic diseases. Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. In: J Allergy Clin Immunol. 137 (5), S. 1347–1358.

Neumann, H. A.M.; Cornu-Thenard, A.; Junger, M.; Mosti, G.; Munte, K.; Partsch, H. et al. (2016): Evidence-based (S3) guidelines for diagnostics and treatment of venous leg ulcers. In: J Eur Acad Dermatol Venereol. 30 (11), S. 1843–1875.

Niebel, D.; Landsberg, J. (2016): Possible Induction of an autoimmune hemolytic Anemia by an abscondal Effect after Radiotherapy under Anti-PD1-Immunotherapy in metastatic Melanoma. In: J Dtsch Dermatol Ges. 14 4, S. 47.

Novak, N. (2012): An update on the role of human dendritic cells in patients with atopic dermatitis. In: J Allergy Clin Immunol. 129 (4), S. 879–886.

Novak, N.; Bieber, T.; Hoffmann, M.; Fölster-Holst, R.; Homey, B.; Werfel, T. et al. (2012): Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. In: J Allergy Clin Immunol. 130 (4), 925-31.e4.

Novak, N.; Mete, N.; Bussmann, C.; Maintz, L.; Bieber, T.; Akdis, M. et al. (2012): Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2. In: J Allergy Clin Immunol. 130 (5), 1153-1158.e2.

Novak, N.; Peng, W. M.; Bieber, T.; Akdis, C. (2013): Fc?RI stimulation promotes the differentiation of histamine receptor 1-expressing inflammatory macrophages. In: Allergy. 68 (4), S. 454–461.

Pannier, F.; Gerlach, H.; Stucker, M.; Schimmelpfennig, L.; Rabe, E. (2012): Guideline. Diagnosis of Venous, the Light-Reflection-Rheography/Photoplethysmography The German Society of Phlebology. In: Phlebologie. 41 (5), S. 261–263.

Pannier, F.; Rabe, E. (2013): How to perform endovenous laser ablation of great saphenous veins? In: Phlebol -Ann Vasc. 66 (2), S. 45–49.

Pannier, F.; Rabe, E. (2015): Progression in venous pathology. In: Phlebology. 30 (1 Suppl), S. 95–97.

Pannier, F.; Rabe, E.; Grp, Guideline (2014): Results from RCTs in Sclerotherapy. European Guidelines for Sclerotherapy in Chronic Venous Disorders. In: Phlebology. 29 1, S. 39–44.

Papp, K. A.; Menter, M. A.; Abe, M.; Elewski, B.; Feldman, S. R.; Gottlieb, A. B. et al. (2015): Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis. Results from two randomized, placebo-controlled, phase III trials. In: Br J Dermatol. 173 (4), S. 949–961.

Paternoster, L.; Standl, M.; Chen, C. M.; Ramasamy, A.; Bønnelykke, K.; Duijts, L. et al. (2012): Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis. In: Nat Genet. 44 (2), S. 187–192.

Paternoster, L.; Standl, M.; Waage, J.; Baurecht, H.; Hotze, M.; Strachan, D. P. et al. (2015): Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. In: Nat Genet. 47 (12), 1449-+.

Patsinakidis, N.; Wenzel, J.; Landmann, A.; Koch, R.; Gerß, J.; Luger, T. A. et al. (2012): Suppression of UV-induced damage by a liposomal sunscreen. A prospective, open-label study in patients with cutaneous lupus erythematosus and healthy controls. In: Exp Dermatol. 21 (12), S. 958–961.

Pavlovi, M. D.; Schuller-Petrovi, S.; Pichot, O.; Rabe, E.; Maurins, U.; Morrison, N.; Pannier, F. (2015): Guidelines of the First International Consensus Conference on Endovenous Thermal Ablation for Varicose Vein Disease--ETAV Consensus Meeting 2012. In: Phlebology. 30 (4), S. 257–273.

Peng, W.; Novak, N. (2014): Recent developments in atopic dermatitis. In: Curr Opin Allergy Clin Immunol. 14 (5), S. 417–422.

Peng, W.; Novak, N. (2015): Pathogenesis of atopic dermatitis. In: Clin Exp Allergy. 45 (3), S. 566–574.

Peng, W. M.; Maintz, L.; Allam, J. P.; Novak, N. (2013): Attenuated TGF-?1 responsiveness of dendritic cells and their precursors in atopic dermatitis. In: Eur J Immunol. 43 (5), S. 1374–1382.

Peng, W. M.; Maintz, L.; Allam, J. P.; Raap, U.; Gütgemann, I.; Kirfel, J. et al. (2013): Increased circulating levels of neurotrophins and elevated expression of their high-affinity receptors on skin and gut mast cells in mastocytosis. In: Blood. 122 (10), S. 1779–1788.

Perrin, M.; Eklof, B.; van Rij, A.; Labropoulos, N.; Vasquez, M.; Nicolaides, A. et al. (2016): Venous symptoms. The SYM Vein Consensus statement developed under the auspices of the European Venous Forum. In: Int Angiol. 35 (4), S. 374–398.

Philipp, S.; Wilsmann-Theis, D.; Weyergraf, A.; Rotterdam, S.; Frambach, Y.; Gerdes, S.; Mössner, R. (2012): Combination of adalimumab with traditional systemic antipsoriatic drugs - a report of 39 cases. In: J Dtsch Dermatol Ges. 10 (11), S. 821–837.

Rabe, E. (2013): In memoriam Dr. med. Jochen Staubesand (dagger) Has Died on the 12th of June 2012, the long-time honorary member of the German Society of Phlebology, Dr. John Staubesand, at the age of 91. In: Phlebologie. 42 (1), S. 43–44.

Rabe, E. (2013): In memoriam Dr. med. Ulrich Dembowski (dagger) Has died on the 22nd of May 2012, our long-standing honorary member, Dr. Ulrich Dembowski, at the blessed age of 91. In: Phlebologie. 42 (1), S. 44–45.

Rabe, E. (2014): The future of phlebology. In: Lasers Med Sci. 29 (2), S. 509–511.

Rabe, E. (2016): Cyanoacrylate adhesive in the treatment of saphenous vein incompetence. Comment on Çal?k et al, page 241-246. In: Vasa. 45 (3), S. 193–194.

Rabe, E.; Agus, G. B.; Roztocil, K. (2015): Analysis of the effects of micronized purified flavonoid fraction versus placebo on symptoms and quality of life in patients suffering from chronic venous disease. From a prospective randomized trial. In: Int Angiol. 34 (5), S. 428–436.

Rabe, E.; Ballarini, S.; Lehr, L.; Group, Doxium EDX09/01 Study (2016): A randomized, double-blind, placebo-controlled, clinical study on the efficacy and safety of calcium dobesilate in the treatment of chronic venous insufficiency. In: Phlebology. 31 (4), S. 264–274.

Rabe, E.; Berboth, G.; Pannier, F. (2016): [Epidemiology of chronic venous diseases]. In: Wien Med Wochenschr. 166 (9-10), S. 260–263.

Rabe, E.; Breu, F. X.; Cavezzi, A.; Smith, P. C.; Frullini, A.; Gillet, J. L. et al. (2014): European guidelines for sclerotherapy in chronic venous disorders. In: Phlebology. 29 (6), S. 338–354.

Rabe, E.; Davies, A. H.; Neumann, H. A.M.; Wittens, C. H.A. (2014): Phlebology education, training and certification in Europe. In: Phlebology. 29 1, S. 186–187.

Rabe, E.; Gerlach, H.; Breu, F. X.; Guggenbichler, S.; Stucker, M.; Pannier, F. (2012): Guideline. Sclerotherapy of Varicose Veins of the German Society of Phlebology (ICD 10:183.0, 183.1, 183.2, 183.9)5 AWMF Guidelines Register No.: 037/015 Stage of Development: S1. In: Phlebologie. 41 (4), S. 206–213.

Rabe, E.; Guex, J. J.; Puskas, A.; Scuderi, A.; Fernandez Quesada, F.; Coordinators, V. C.P. et al. (2012): Epidemiology of chronic venous disorders in geographically diverse populations. Results from the Vein Consult Program. In: Int Angiol. 31 (2), S. 105–115.

Rabe, E.; Hartmann, K.; Gerlach, H.; Stucker, M.; Schimmelpfennig, L.; Pannier, F. (2012): Guideline. Venous diagnostics with the Phlebodynamometry The German Society of Phlebology. In: Phlebologie. 41 (5), S. 259–260.

Rabe, E.; Hertel, S.; Bock, E.; Hoffmann, B.; Jöckel, K. H.; Pannier, F. (2013): Therapy with compression stockings in Germany - results from the Bonn Vein Studies. In: J Dtsch Dermatol Ges. 11 (3), S. 257–261.

Rabe, E.; Pannier, F. (2015): Embolization is not essential in the treatment of leg varices due to pelvic venous insufficiency. In: Phlebology. 30 (1 Suppl), S. 86–88.

Rabe, E.; Pannier, F. (2016): Response to letter regarding Embolization is not essential in the treatment of leg varices due to pelvic venous insufficiency. In: Phlebology. 31 (8), S. 589.

Rabe, E.; Pannier, F. (2016): The post-thrombotic syndrome Frequency, Diagnosis and Prevention. In: Phlebologie. 45 (4), S. 220–223.

Rabe, E.; Pannier, F.; Grp, Guideline (2014): Indications, contraindications and performance. European Guidelines for Sclerotherapy in Chronic Venous Disorders. In: Phlebology. 29 1, S. 26–33.

Ramis, B. B.; Reinhardt, J.; Tuting, T.; Landsberg, J. (2016): Histopathological Characterization and prognostic Importance of the Expression of the Ecto-5'-Nucleotidase CD73 in Melanoma. In: J Dtsch Dermatol Ges. 14 4, S. 24.

Ramos, D. A.L.; Bald, T.; Holzel, M.; Tuting, T. (2016): A functional type I IFN system in myeloid immune cells is required for effective adoptive T cell immunotherapy of melanoma. In: Exp Dermatol. 25 (3), E37-E37.

Rebane, A.; Zimmermann, M.; Aab, A.; Baurecht, H.; Koreck, A.; Karelson, M. et al. (2012): Mechanisms of IFN-?-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. In: J Allergy Clin Immunol. 129 (5), S. 1297–1306.

Rebane, A.; Zimmermann, M.; Aab, A.; Ruckert, B.; Baurecht, H.; Weidinger, S. et al. (2012): From miRNA and mRNA expression profiling to function of keratinocytes in atopic dermatitis. In: Allergy. 67 96, S. 57.

Reckenbeil, J.; Kraus, D.; Probstmeier, R.; Allam, J. P.; Novak, N.; Frentzen, M. et al. (2016): Cellular Distribution and Gene Expression Pattern of Metastasin (S100A4), Calgranulin A (S100A8), and Calgranulin B (S100A9) in Oral Lesions as Markers for Molecular Pathology. In: Cancer Invest. 34 (6), S. 246–254.

Redler, S.; Pasternack, S. M.; Wolf, S.; Stienen, D.; Wenzel, J.; Nöthen, M. M.; Betz, R. C. (2015): A novel KRT86 mutation in a Turkish family with monilethrix, and identification of maternal mosaicism. In: Clin Exp Dermatol. 40 (7), S. 781–785.

Rehkamper, C.; Allam, J. P.; Haidl, G.; Bieber, T.; Wilsmann-Theis, D. (2013): Pustular Psoriasis in Hypogonadism and Chromosome Abnormalities. In: J Dtsch Dermatol Ges. 11 (11), S. 1105–1106.

Rehkamper-Schafer, C.; Bieber, T.; Altengarten, J. (2014): Cutis marmorata teleangiectatica congenita (Van- Lohuizen- Syndrome). In: J Dtsch Dermatol Ges. 12 (12), E2-E2.

Reich-Schupke, S.; Alm, J.; Altmeyer, P.; Bachter, D.; Bayerl, C.; Beissert, S. et al. (2013): [Phlebology in German departments of dermatology. An analysis on behalf of the German Society of Phlebology]. In: Hautarzt. 64 (9), S. 685–694.

Reinhardt, J.; Landsberg, J.; Riesenberg, S.; Schmid-Burgk, J.; Nettersheim, D.; van den Boorn, D. et al. (2016): CD73 correlates with an inflammatory mesenchymal cell state in melanoma and is regulated via MAPK signaling. In: Exp Dermatol. 25 (3), E44-E44.

Renn, M.; Bald, T.; Landsberg, J.; Sporleder, A.; Mikus, S.; Tuting, T. (2012): Cytosolically targeted isRNA induces melanoma destruction via type I interferon signaling on myeloid cells in the tumor microenvironment. In: Immunology. 137 1, S. 709.

Renn, M.; Bald, T.; Sporleder, A.; Mikus, S.; Landsberg, J.; Tuting, T. (2012): Mda5 activation and type I interferon signaling in the microenvironment seems to be more important for melanoma therapy with cytosolically targeted isRNA than direct induction of apoptosis in tumor cells. In: Exp Dermatol. 21 (3), e32-e32.

Renn, M. R.; Bald, T.; Landsberg, J.; Cron, M.; Lopez, D.; Tuting, T. (2013): Effective melanoma immunotherapy with cytosolically targeted pIC requires type I IFN-dependent activation of NK cells by myeloid immune cells. In: Exp Dermatol. 22 (3), E39-E40.

Resch, Y.; Blatt, K.; Malkus, U.; Swoboda, I.; Seiberler, S.; Mittermann, I. et al. (2012): Molecular and immunological characterization of Der p 18, a chitinase-like house dust mite allergen. In: Immunology. 137 1, S. 456.

Reuten, R.; Patel, T. R.; McDougall, M.; Rama, N.; Nikodemus, D.; Gibert, B. et al. (2016): Structural decoding of netrin-4 reveals a regulatory function towards mature basement membranes. In: Nat Commun. 7, S. 13515.

Rhinitis, W. Collaborating Center for Asthma andH.O.; Bousquet, J.; Anto, J. M.; Demoly, P.; Schünemann, H. J.; Togias, A. et al. (2012): Severe chronic allergic (and related) diseases. A uniform approach--a MeDALL--GA2LEN--ARIA position paper. In: Int Arch Allergy Immunol. 158 (3), S. 216–231.

Riesenberg, S.; Groetchen, A.; Siddaway, R.; Bald, T.; Reinhardt, J.; Smorra, D. et al. (2015): MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment. In: Nat Commun. 6, S. 8755.

Riesenberg, S.; Reinhardt, J.; Davidson, I.; Goding, R.; Jonsson, G.; Landsberg, J. et al. (2016): MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment. In: Exp Dermatol. 25 (3), E43-E44.

Ring, J.; Akdis, C.; Behrendt, H.; Lauener, R. P.; Schappi, G.; Akdis, M. et al. (2012): Davos declaration. Allergy as a global problem (vol 67, pg 141, 2012). In: Allergy. 67 (5), S. 712.

Ring, J.; Akdis, C.; Lauener, R.; Schäppi, G.; Traidl-Hoffmann, C.; Akdis, M. et al. (2014): Global Allergy Forum and Second Davos Declaration 2013 Allergy. Barriers to cure--challenges and actions to be taken. In: Allergy. 69 (8), S. 978–982.

Ring, J.; Alomar, A.; Bieber, T.; Deleuran, M.; Fink-Wagner, A.; Gelmetti, C. et al. (2012): Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. In: J Eur Acad Dermatol Venereol. 26 (9), S. 1176–1193.

Rodriguez, E.; Baurecht, H.; Wahn, A. F.; Kleinschmidt, A.; Hotze, M.; Zeilinger, S. et al. (2014): A pilot study on DNA methylation and RNA expression in diverse tissues reveals epigenetic changes in atopic dermatitis. In: Exp Dermatol. 23 (3), E20-E20.

Rodríguez, E.; Baurecht, H.; Wahn, A. F.; Kretschmer, A.; Hotze, M.; Zeilinger, S. et al. (2014): An integrated epigenetic and transcriptomic analysis reveals distinct tissue-specific patterns of DNA methylation associated with atopic dermatitis. In: J Invest Dermatol. 134 (7), S. 1873–1883.

Roesch, A.; Paschen, A.; Landsberg, J.; Helfrich, I.; Becker, J. C.; Schadendorf, D. (2016): Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma. In: Eur J Cancer. 59, S. 109–112.

Rogava, M.; Bald, T.; Glodde, N.; Tuting, T.; Gaffal, E. (2014): Sensing of UVB-induced DNA damage in the skin by the innate immune system involves the TLR4-and MyD88-dependent signaling pathway. In: Exp Dermatol. 23 (3), E39-E39.

Rogava, M.; Bald, T.; Shridhar, N.; van den Boorn-Konijnenberg, D.; Schmid-Burgk, J.; Hornung, V. et al. (2016): Tumor cell intrinsic TLR4 signaling promotes tumor growth and metastasis. In: Eur J Immunol. 46 1, S. 352–353.

Ruotsalainen, J.; Hinkkanen, A.; Tuting, T. (2016): Human melanoma cells show a broad range of responsiveness to type I interferons and susceptibility to oncolytic alphavirus infection. In: Exp Dermatol. 25 (3), E39-E39.

Sabet, A.; Ahmadzadehfar, H.; Schmid-Wendtner, M. H.; Hinterthaner, B.; Biersack, H. J.; Ezziddin, S. (2013): The impact of 18F-FDG-PET-CT findings in the management of a patient with Mycosis Fungoides. In: Int J Radiat Res. 11 (2), S. 127–129.

Schaarschmidt, H.; Baurecht, H.; Rodriguez, E.; Ellinghaus, D.; Lieb, W.; Novak, N. et al. (2014): A genome-wide association study reveals two new susceptibility loci for atopic dermatitis. In: J Invest Dermatol. 134 2, S4-S4.

Schaarschmidt, H.; Ellinghaus, D.; Rodríguez, E.; Kretschmer, A.; Baurecht, H.; Lipinski, S. et al. (2015): A genome-wide association study reveals 2 new susceptibility loci for atopic dermatitis. In: J Allergy Clin Immunol. 136 (3), S. 802–806.

Schäfer, S. T.; Franken, L.; Adamzik, M.; Schumak, B.; Scherag, A.; Engler, A. et al. (2016): Mitochondrial DNA. An Endogenous Trigger for Immune Paralysis. In: Anesthesiology. 124 (4), S. 923–933.

Schiffbauer, J.; Christ, L.; Allam, J. P.; Wenzel, J.; Ehler, L.; Bieber, T. (2013): Atypical Mycobacterial Infection in a 67-year old Owner of an Aquarium. In: J Dtsch Dermatol Ges. 11 (11), S. 1108.

Schmid-Wendtner, M.; Hornung, T.; Meurer, M.; Wendtner, C. M. (2015): [Skin disorders in malignant hematologic diseases]. In: Hautarzt. 66 (8), 625-33; quiz 634.

Schmitt, J.; Schwarz, K.; Baurecht, H.; Hotze, M.; Fölster-Holst, R.; Rodríguez, E. et al. (2016): Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes. In: J Allergy Clin Immunol. 137 (1), S. 130–136.

Schmitz, A. L.; Schrage, R.; Gaffal, E.; Charpentier, T. H.; Wiest, J.; Hiltensperger, G. et al. (2014): A cell-permeable inhibitor to trap G?q proteins in the empty pocket conformation. In: Chem Biol. 21 (7), S. 890–902.

Schneider, L.; Tilles, S.; Lio, P.; Boguniewicz, M.; Beck, L.; LeBovidge, J. et al. (2013): Atopic dermatitis. A practice parameter update 2012. In: J Allergy Clin Immunol. 131 (2), 295-9.e1.

Schnell, L.; Wilsmann-Theis, D.; Novak, N.; Haidl, G.; Allam, J. P. (2015): Decreased Serum- Testosterone Levels correlate with Psorias- Severity in Men. In: J Dtsch Dermatol Ges. 13 1, S. 92.

Schrage, R.; Schmitz, A. L.; Gaffal, E.; Annala, S.; Kehraus, S.; Wenzel, D. et al. (2015): The experimental power of FR900359 to study Gq-regulated biological processes. In: Nat Commun. 6, S. 10156.

Schuppe, H. C.; Haidl, G.; Ochsendorf, F. (2015): [In Process Citation]. In: Hautarzt. 66 (12), S. 890–891.

Schwandt, T.; Schumak, B.; Gielen, G. H.; Jungerkes, F.; Schmidbauer, P.; Klocke, K. et al. (2012): Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis. In: EMBO J. 31 (1), S. 201–213.

Shaikhibrahim, Z.; Offermann, A.; Halbach, R.; Vogel, W.; Braun, M.; Kristiansen, G. et al. (2015): Clinical and molecular implications of MED15 in head and neck squamous cell carcinoma. In: Am J Pathol. 185 (4), S. 1114–1122.

Shridhar, N.; Bald, T.; Huttner, C.; Meyer, M.; Tuting, T. (2016): Dickkopf 3 (DKK3) deficiency delays the onset and progression of primary melanomas in HGF-CDK4 mice. In: Exp Dermatol. 25 (3), E39-E39.

Simon, D.; Bieber, T. (2014): Systemic therapy for atopic dermatitis. In: Allergy. 69 (1), S. 46–55.

Simpson, E. L.; Bieber, T.; Eckert, L.; Wu, R.; Ardeleanu, M.; Graham, N. M. et al. (2016): Patient burden of moderate to severe atopic dermatitis (AD). Insights from a phase 2b clinical trial of dupilumab in adults. In: J Am Acad Dermatol. 74 (3), S. 491–498.

Simpson, E. L.; Bieber, T.; Guttman-Yassky, E.; Beck, L. A.; Blauvelt, A.; Cork, M. J. et al. (2016): Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. In: N Engl J Med. 375 (24), S. 2335–2348.

Sistigu, A.; Yamazaki, T.; Vacchelli, E.; Chaba, K.; Enot, D. P.; Adam, J. et al. (2014): Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. In: Nat Med. 20 (11), S. 1301–1309.

Sonneck, M.; Bald, T.; Tuting, T.; Gaffal, E. (2016): Impaired UV - induced angiogenic response in the skin of TNF-deficient mice. In: Exp Dermatol. 25 (3), E41-E41.

Sporbert, F.; Zollmann, C.; Zollmann, P.; Veltman, J.; Graser, A.; Berger, I.; Rabe, E. (2016): Endoluminal thermal ablation of the great saphenous vein (GSV) insufficiency. In: Phlebologie. 45 (6), S. 357–362.

Staudacher, A.; Hinz, T.; Novak, N.; Bubnoff, D. von; Bieber, T. (2015): Exaggerated IDO1 expression and activity in Langerhans cells from patients with atopic dermatitis upon viral stimulation. A potential predictive biomarker for high risk of Eczema herpeticum. In: Allergy. 70 (11), S. 1432–1439.

Stücker, M.; Debus, E. S.; Hoffmann, J.; Jünger, M.; Kröger, K.; Mumme, A. et al. (2016): Consensus statement on the symptom-based treatment of chronic venous diseases. In: J Dtsch Dermatol Ges. 14 (6), S. 575–583.

Tang, T.; Bieber, T.; Williams, H. (2012): Does. In: J Invest Dermatol. 132 2, S34-S34.

Tang, T. S.; Bieber, T.; Williams, H. C. (2012): Does "autoreactivity" play a role in atopic dermatitis? In: J Allergy Clin Immunol. 129 (5), 1209-1215.e2.

Tang, T. S.; Bieber, T.; Williams, H. C. (2014): Are the concepts of induction of remission and treatment of subclinical inflammation in atopic dermatitis clinically useful? In: J Allergy Clin Immunol. 133 (6), 1615-25.e1.

Tang, T. S.; Bieber, T.; Williams, H. C. (2014): Are the concepts of induction of remission and treatment of subclinical inflammation in atopic dermatitis clinically useful? In: Br J Dermatol. 170 (6), E12-E12.

Tanno, L. K.; Darlenski, R.; Sánchez-Garcia, S.; Bonini, M.; Vereda, A.; Kolkhir, P. et al. (2016): International survey on skin patch test procedures, attitudes and interpretation. In: World Allergy Organ J. 9, S. 8.

Thaçi, D.; Simpson, E. L.; Beck, L. A.; Bieber, T.; Blauvelt, A.; Papp, K. et al. (2016): Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments. A randomised, placebo-controlled, dose-ranging phase 2b trial. In: Lancet. 387 (10013), S. 40–52.

Tolksdorf, F.; Rieck, M.; Novak, N.; Quast, T.; Grell, J.; Kolanus, W. (2012): Cytohesins regulate static adhesion, MAP kinase signaling, and T cell receptor internalization in T cells through a GEF-dependent manner. In: Immunology. 137 1, S. 373.

Tüting, T. (2013): T cell immunotherapy for melanoma from bedside to bench to barn and back. How conceptual advances in experimental mouse models can be translated into clinical benefit for patients. In: Pigment Cell Melanoma Res. 26 (4), S. 441–456.

Ullmann, J. F.; Mangold, E.; Schade, G.; Thomas, N.; Wenzel, J.; Woelfle, J. (2015): Congenital Hoarseness combined with conspicuous Skin-and Mucous Membrane Features. In: Monatsschr Kinderheilkd. 163 (2), S. 105–107.

van Beek, N.; Knuth-Rehr, D.; Altmeyer, P.; Assaf, C.; Babilas, P.; Bayerl, C. et al. (2012): Diagnostics of autoimmune bullous diseases in German dermatology departments. In: J Dtsch Dermatol Ges. 10 (7), S. 492–499.

van den Boorn, J. G.; Jakobs, C.; Hagen, C.; Renn, M.; Luiten, R. M.; Melief, C. J. et al. (2016): Inflammasome-Dependent Induction of Adaptive NK Cell Memory. In: Immunity. 44 (6), S. 1406–1421.

Vieths, S.; Bieber, T. (2013): [Personalised medicine for the diagnosis and treatment of allergic diseases]. In: Bundesgesundheitsblatt Gesundheitsforschung, Gesundheitsschutz. 56 (11), S. 1531–1537.

Voth, H.; Wenzel, J.; Bieber, T.; Landsberg, J. (2013): Phymatous transformation of facial cutaneous vascular malformations. Clues to phyma pathogenesis. In: JAMA Dermatol. 149 (3), S. 368–369.

Weidinger, S.; Novak, N. (2014): Atopic dermatitis revisited. In: Allergy. 69 (1), S. 1–2.

Weidinger, S.; Novak, N. (2016): Atopic dermatitis. In: Lancet. 387 (10023), S. 1109–1122.

Weidinger, S.; Willis-Owen, S. A.; Kamatani, Y.; Baurecht, H.; Liang, L.; Rodriguez, E. et al. (2014): A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis. In: Exp Dermatol. 23 (3), E21-E21.

Weidinger, S.; Willis-Owen, S. A.; Kamatani, Y.; Baurecht, H.; Morar, N.; Liang, L. et al. (2013): A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis. In: Hum Mol Genet. 22 (23), S. 4841–4856.

Weisenseel, P.; Wilsmann-Theis, D.; Kahl, C.; Reich, K.; Mössner, R. (2016): [Pustular psoriasis]. In: Hautarzt. 67 (6), S. 445–453.

Weißbach, A.; Herberhold, S.; Wenzel, J.; Löffler, K. U. (2014): [Eyelid swelling of unclear genesis]. In: Ophthalmologe. 111 (1), S. 65–68.

Wenzel, J. (2013): Overactivation of the innate Immune System in Dermatomyositis. Clinical, Diagnostic and Therapeutic Significance. In: J Dtsch Dermatol Ges. 11 2, S. 40.

Wenzel, J.; van Holt, N.; Maier, J.; Vonnahme, M.; Bieber, T.; Wolf, D. (2016): JAK1/2 Inhibitor Ruxolitinib Controls a Case of Chilblain Lupus Erythematosus. In: J Invest Dermatol. 136 (6), S. 1281–1283.

Werfel, T.; Allam, J. P.; Biedermann, T.; Eyerich, K.; Gilles, S.; Guttman-Yassky, E. et al. (2016): Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. In: J Allergy Clin Immunol. 138 (2), S. 336–349.

Werth, S.; Bauersachs, R.; Gerlach, H.; Rabe, E.; Schellong, S.; Beyer-Westendorf, J. (2016): Superficial vein thrombosis treated for 45 days with rivaroxaban versus fondaparinux. Rationale and design of the SURPRISE trial. In: J Thromb Thrombolysis. 42 (2), S. 197–204.

Wilsmann-Theis, D.; Bieber, T. (2014): [Psoriasis and eczema on the scalp]. In: Hautarzt. 65 (12), S. 1043–1049.

Wilsmann-Theis, D.; Frambach, Y.; Philipp, S.; Weyergraf, A. J.; Jacobi, A.; Mössner, R.; Gerdes, S. (2015): Systemic antipsoriatic combination therapy with fumaric acid esters for plaque-type psoriasis. Report on 17 cases. In: Dermatology. 230 (2), S. 119–127.

Wilsmann-Theis, D.; Fronhoffs, K.; Ehler, L. K.; Wenzel, J.; Bieber, T.; Klingmueller, K. (2014): Low-dose methotrexate - a therapeutical kick in TNF-alpha antagonist treatment for recalcitrant psoriasis vulgaris. In: Dermatol Ther. 27 (1), S. 55–59.

Wilsmann-Theis, D.; Koch, S.; Mindnich, C.; Bonness, S.; Schnautz, S.; Bubnoff, D. von; Bieber, T. (2013): Generation and functional analysis of human TNF-?/iNOS-producing dendritic cells (Tip-DC). In: Allergy. 68 (7), S. 890–898.

Wilsmann-Theis, D.; Wagenpfeil, J.; Holzinger, D.; Roth, J.; Koch, S.; Schnautz, S. et al. (2016): Among the S100 proteins, S100A12 is the most significant marker for psoriasis disease activity. In: J Eur Acad Dermatol Venereol. 30 (7), S. 1165–1170.

Winter, J.; Mohr, S.; Pantelis, A.; Kraus, D.; Allam, J. P.; Novak, N. et al. (2012): IGF-1 deficiency in combination with a low basic hBD-2 and hBD-3 gene expression might counteract malignant transformation in pleomorphic adenomas in vitro. In: Cancer Invest. 30 (2), S. 106–113.

Winter, J.; Pantelis, A.; Kraus, D.; Reckenbeil, J.; Reich, R.; Jepsen, S. et al. (2012): Human ?-defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours. In: BMC Cancer. 12, S. 465.

Wittens, C. H.; Neumann, H. A.; Rabe, E.; Davies, A. H. (2013): The future of phlebology in Europe. In: Phlebology. 28 (3), S. 121–122.

Wolk, K.; Witte, E.; Tsaousi, A.; Witte, K.; Volk, H.; Sterry, W. et al. (2016): Lipocalin-2 as a novel biomarker in Acne inversa. In: J Invest Dermatol. 136 2 (9), S235-S235.

Wolk, K.; Witte, K.; Tsaousi, A.; Volk, H. D.; Sterry, W.; Wenzel, J. et al. (2016): A role of lipocalin-2 in acne inversa. In: Exp Dermatol. 25 2, S. 1.

Wrona, M.; Jöckel, K. H.; Pannier, F.; Bock, E.; Hoffmann, B.; Rabe, E. (2015): Association of Venous Disorders with Leg Symptoms. Results from the Bonn Vein Study 1. In: Eur J Vasc Endovasc Surg. 50 (3), S. 360–367.

Zahn, S.; Graef, M.; Barchet, W.; Bieber, T.; Tüting, T.; Wenzel, J. (2013): Nitrosative stress. A hallmark of the junctional inflammation in cutaneous lupus erythematosus. In: Clin Exp Dermatol. 38 (1), S. 96–97.

Zahn, S.; Graef, M.; Patsinakidis, N.; Landmann, A.; Surber, C.; Wenzel, J.; Kuhn, A. (2014): Ultraviolet light protection by a sunscreen prevents interferon-driven skin inflammation in cutaneous lupus erythematosus. In: Exp Dermatol. 23 (7), S. 516–518.

Zahn, S.; Maier, J.; Bieber, T.; Tuting, T.; Wenzel, J. (2016): Self DNA stimulates keratinocytes to produce IFN-regulated chemokines. Implications for the pathogenesis of cutaneous lupus erythematosus. In: Exp Dermatol. 25 (3), E28-E29.

Zahn, S.; Orthmann, J.; Sharma, S.; Bieber, T.; Tuting, T.; Wenzel, J. (2012): Tyrosine kinase inhibitor SU6668 blocks the nucleic-acid-induced IFN lambda-expression of keratinocytes. TBK1 as a potential drug-target for the treatment of cutaneous lupus erythematosus. In: Exp Dermatol. 21 (3), e11-e11.

 

Artikelaktionen